POMALYST® (pomalidomide) homepage

This site is intended for US audiences only.

POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.

The REMS Companion App

Easily access the POMALYST REMS® program.

Download now
FREQUENTLY ASKED QUESTIONS

Questions? Browse our FAQs page for answers.

LEARN MORE
CONVERSATION STARTER

Find tips and questions to help you and your caregiver talk to your healthcare team.

GET STARTED
Hypothetical POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma and their healthcare team
Hypothetical POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma and their healthcare team

Not an actual patient.

PLANNING YOUR ROUTINE

Stay organized with your treatment schedule and doctor appointments.

DOWNLOAD NOW
PATIENT & CAREGIVER ORGANIZATIONS

Find organizations that provide support and education around relapsed/refractory multiple myeloma.

LEARN MORE
Hypothetical caregiver and a POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma outdoors
Hypothetical caregiver and a POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma outdoors

Not an actual patient.

DOWNLOADS

You’ll find other helpful tools and resources to learn about POMALYST here.

Explore

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.